A high platelet count is not a reason to assume that PRP will work better. If your blood count has a significant unexplained abnormality, it should be investigated before a joint or tendon PRP injection. Bring the full report and any previous results to the assessment so the clinician can decide what the result means for your health and the proposed procedure.
The useful question is not simply whether enough platelets can be collected. It is why the count is raised, whether the finding is temporary or persistent, whether a blood disorder is present and whether an elective injection is appropriate. A careful assessment can prevent you booking a procedure before a more important problem has been understood.
Why more platelets do not automatically mean better PRP
PRP is prepared from a sample of your own blood. However, the platelet number on a routine full blood count is not a validated personal score for how much benefit an injection will produce. Your diagnosis, the tissue being treated, your general health and the preparation used all matter. The American Academy of Orthopaedic Surgeons explains that PRP evidence and results vary between conditions and preparations.
A high platelet count also does not show that those platelets function normally. Mayo Clinic distinguishes reactive thrombocytosis, in which another condition stimulates platelet production, from essential thrombocythaemia, a bone marrow disorder. These have different implications. Neither should be diagnosed from a booking message or a single isolated number.
This distinction matters when a treatment is marketed using the idea of concentrated platelets. Concentrating a blood sample is not a substitute for establishing that the sample and the person having treatment are suitable. An abnormal result deserves clinical context, not a claim that you have an advantage.
What the result may mean
A raised platelet count can occur with infection, inflammation, iron deficiency, blood loss, recent surgery or removal of the spleen. There are other causes, including bone marrow disorders. This list is not a diagnosis or a reason to assume the most serious explanation. The pattern, symptoms, medical history and other blood results help determine the next step.
Your clinician may compare earlier results and consider whether repeat testing or other investigations are needed. Mayo Clinic describes possible tests for iron status, inflammation and gene changes, with bone marrow testing in selected cases. These are not a standard shopping list for every patient with one raised result. The assessment should establish which tests, if any, answer your particular question.
Tell the clinician about recent illness or surgery and any existing haematology diagnosis. A result that has already been assessed by your usual doctor is different from a new unexplained finding, but it still needs to be considered alongside the proposed injection and your current treatment.
Ask The London PRP Clinic about assessment before a joint or tendon injection. Explain that your platelet count is raised and whether your usual clinician has investigated it. Ask how to provide the report through the appropriate secure route before arranging treatment.
What the PRP guidance actually says
A 2025 formal consensus from the International Research Group on Platelet Injections recommends investigating a significant blood-count abnormality before musculoskeletal PRP. It does not provide a universal high-platelet cutoff that makes everyone eligible or ineligible. The recommendations address joint and tendon disease, not proof of safety or effectiveness for hair or facial PRP.
The same consensus distinguishes different haematological conditions. Some situations need agreement from the treating haematologist; an active or unstable blood malignancy requires particular caution. A familiar diagnosis, a stable result or a previous injection should not be treated as automatic clearance for a new procedure.
These recommendations are useful clinical guidance, but the authors explain that much of the supporting evidence is limited and based mainly on expert opinion. They do not prove that PRP benefits a person with thrombocytosis. The decision still needs an individual benefit-risk assessment and consideration of other treatments.
What to bring to the consultation
Bring the complete full blood count with its date, units and laboratory reference ranges, rather than a cropped platelet number. Include previous blood counts, relevant specialist letters and your current medicine list with doses. Mention previous blood clots, unusual bleeding or bruising and any planned investigations.
If you have essential thrombocythaemia or another blood disorder, bring your haematology plan and the contact details of your treating service. Ask whether the PRP clinician needs further information or specialist agreement before any injection is booked. Coordination should happen with your consent and through a suitable route.
Do not start aspirin to address the result yourself, and do not stop prescribed aspirin, anticoagulants or other medicines to fit a generic PRP preparation sheet. Mayo Clinic specifically advises checking with the healthcare team before taking aspirin for thrombocytosis. Any procedural medicine plan should be agreed with the relevant prescriber.
When the injection is not the priority
New chest pain, sudden breathlessness, stroke symptoms or severe bleeding need urgent or emergency assessment rather than an elective PRP appointment. Call 999 in a medical emergency. Do not wait for a routine booking reply to interpret these symptoms.
Without emergency symptoms, an unexplained raised count still deserves follow-up with the clinician responsible for the result. Ask who will arrange the investigation and review it. An elective treatment date should not become a reason to rush past that work or assume that a repeat result will be reassuring.
Agree the care plan before paying for treatment
A useful consultation should leave you knowing whether PRP is being considered for a confirmed joint or tendon diagnosis, what other treatments are available and whether blood-count investigation must come first. If the procedure is deferred, ask who owns the next step and what information is needed before reconsidering it.
Discuss your joint or tendon treatment plan with The London PRP Clinic. Ask what the assessment covers, how specialist coordination is arranged and which consultation, investigation and treatment costs apply. Appointment availability and suitability are confirmed individually; an enquiry does not reserve an injection or establish medical clearance.
Sources and evidence limits
Eymard and colleagues: 2025 GRIIP consensus on PRP and infectious, oncological and haematological conditions supports investigation of significant blood-count abnormalities before musculoskeletal PRP. Many recommendations rely mainly on expert opinion.
Mayo Clinic: thrombocytosis symptoms and causes explains reactive thrombocytosis and essential thrombocythaemia.
Mayo Clinic: thrombocytosis diagnosis and treatment explains individual investigation and treatment, including the warning not to start aspirin without clinical advice.
American Academy of Orthopaedic Surgeons: platelet-rich plasma discusses preparation, condition-specific evidence and treatment uncertainty.
Sources checked 6 November 2026. This article is general information, not a diagnosis, a platelet threshold for treatment or personal clearance for an injection.